Nitorum Capital, L.P. United Therapeutics Corp Transaction History
Nitorum Capital, L.P.
- $684 Million
- Q4 2024
A detailed history of Nitorum Capital, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 95,420 shares of UTHR stock, worth $35.1 Million. This represents 4.92% of its overall portfolio holdings.
Number of Shares
95,420
Previous 113,328
15.8%
Holding current value
$35.1 Million
Previous $40.6 Million
17.1%
% of portfolio
4.92%
Previous 4.51%
Shares
6 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.73 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.63 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$1.01 Billion14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$905 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...